Recombinant Human GM-CSF Protein, CF 215-GM-010/CF from R&D Systems, a Bio-Techne Brand

Product Specs
ItemRecombinant Human GM-CSF Protein, CF
CompanyR&D Systems, a Bio-Techne Brand
Price $269.00Supplier Page View Company Product Page
Catalog Number215-GM-010/CF
FormatLyophilized from a 0.2 µm filtered solution in PBS
Source/Expression SystemE. coli-derived Recombinant Human GM-CSF Protein, CF
Size10 ug (also 50 ug)
Molecule NameGM-CSF
NCBI Full Gene Namecolony stimulating factor 2
NCBI Gene AliasesCSF, GMCSF
Purity>97%, by SDS-PAGE under reducing conditions and visualized by silver stain
Molecular Weight14 kDa
ApplicationsBioactivity
Conjugate/TagUnconjugated
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution
SpeciesHuman

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) Monoallelic TYROBP deletion is a novel risk factor for Alzheimer's diseaseMolecular neurodegenerationApril 29, 2025Martiskainen H, Willman RM, Harju P, Heikkinen S, Heiskanen M, Müller SA, Sinisalo R, Takalo M, Mäkinen P, Kuulasmaa T, et al.recombinant cytokines: M-CSF (10 ng/ml, #574,804, Biolegend, San Diego, CA, USA), GM-CSF (10 ng/ml, #215-GM- 010/CF, R&D Systems, Minneapolis, MN, USA), NGF-β (10 ng/ml, #256-GF- 100, R&D Systems), CCL2 (100 ng/ml, #571,404,

(2) Prolyl hydroxylase inhibitor desidustat improves stroke outcomes via enhancing efferocytosis in mice with chronic kidney diseaseExperimental NeurologyApril 1, 2025Harpreet Kaur, Nilesh Pandey, Lakshmi Chandaluri, Nirvana Shaaban, Alexa Martinez, Evan Kidder, Vishal J. Pate.l, Samadhan G. Kshirsagar, Dhananjay Kumar, Louise Frausto, et al.and a combination of recombinant human cytokines: GM-CSF (10 ng/mL; R&D Systems, Minneapolis, MN, #215-GM-010/CF) and IL-34 (100 ng/mL; R&D Systems, Minneapolis, MN, #5265-IL-010/CF). The cells were maintained for

(3) Interferon-gamma rescues dendritic cell calcineurin-dependent responses to Aspergillus fumigatus via Stat3 to Stat1 switchingiScienceFebruary 21, 2025Amit Adlakha, Thomas J. Williams, Xinxin Shou, Anna K. Reed, Boris Lenhard, Darius Armstrong-Jamesproteins","Chemicals, peptides, and recombinant proteins" ,, Recombinant GM-CSF,R&D Systems,Cat# 215-GM-010/CF Recombinant IL-4,Peprotech,Cat# 200-04-20UG Tacrolimus (FK506),Selleckchem,Cat# S5003 Recombinant

(4) Cognate antigen engagement induces HIV-1 expression in latently infected CD4+ T cells from people on long-term antiretroviral therapyImmunityDecember 1, 2024Milica Moskovljevic, Filippo Dragoni, Nathan L. Board, Fengting Wu, Jun Lai, Hao Zhang, James R. White, Rebecca Hoh, Kenneth Lynn, Pablo Tebas, et al."Recombinant Human IL-4 Protein, CF",R&D Systems,Cat# 204-IL-020/CF "Recombinant Human GM-CSF Protein, CF",R&D Systems,Cat#215-GM-010/CF PepMix™ HIV-1 (Con B gag motif),JPT Peptide Technologies,Cat# PM-HIV-CONB CMV Infected Cell extract,Virusys

(5) CD33 and SHP-1/PTPN6 Interaction in Alzheimer’s DiseaseGenes (Basel)September 13, 2024Lien Beckers, Mamunur Rashid, Annie J. Lee, Zena K. Chatila, Kirstin A. Tamucci, Ryan C. Talcoff, Jennifer L. Hall, David A. Bennett, Badri N. Vardarajan, Elizabeth M. Bradshawgranulocyte-macrophage colony-stimulating factor (GM-CSF; 10 ng/mL; R&D Systems, Minneapolis, MN, USA, 215-GM-010/CF), nerve growth factor–β (NGF-β; 10 ng/mL; R&D Systems, 256-GF-100), chemokine ligand 2 (CCL2; 100 ng/mL;

(6) Linking adipose tissue eosinophils, IL-4, and leptin in human obesity and insulin resistanceJCI insightFebruary 8, 2024Hernandez JD, Li T, Ghannam H, Rau CM, Masuda MY, Madura JA 2nd, Jacobsen EA, De Filippis E.A5955-100ML), 1 ng/mL of human IL-5 (R&D Systems, 205-IL-005/CF), 5 ng/mL of human GM-CSF (R&D Systems, 215-GM-010/CF), and 50 ng/mL of human IL-33 (R&D Systems, 3625-IL-010/CF) for 16 hours at 37°C, 5% CO2. After incubation,

(7) Tandem detergent-extraction and immunoprecipitation of proteinopathy: Scalable enrichment of ALS-associated TDP-43 aggregatesiScienceMay 19, 2023Evangelista BA, Cahalan SR, Ragusa JV, Mordant A, Necarsulmer JC, Perna RJ, Ajit T, White K, Barker NK, Tian X, et al.presence of 15 ng/ml human granulocyte–macrophage colony stimulating factor (rhGM-CSF; R&D Systems # 215-GM-010/CF). Non-adherent cells were aspirated and differentiated macrophages were maintained with half-media changes

(8) Combination IFNβ and Membrane-Stable CD40L Maximize Tumor Dendritic Cell Activation and Lymph Node Trafficking to Elicit Systemic T-cell ImmunityCancer immunology researchApril 3, 2023Zheng H, Yu X, Ibrahim ML, Foresman D, Xie M, Johnson JO, Boyle TA, Ruffell B, Perez BA, Antonia SJ, et al.

(9) TRIM21 inhibits irradiation-induced mitochondrial DNA release and impairs antitumour immunity in nasopharyngeal carcinoma tumour modelsNature communicationsFebruary 16, 2023Li JY, Zhao Y, Gong S, Wang MM, Liu X, He QM, Li YQ, Huang SY, Qiao H, Tan XR, et al.

(10) Cancer cell-derived type I interferons instruct tumor monocyte polarizationCell reportsDecember 6, 2022Kwart D, He J, Srivatsan S, Lett C, Golubov J, Oswald EM, Poon P, Ye X, Waite J, Zaretsky AG, et al.

(11) Neutralizing GM-CSF autoantibodies in pulmonary alveolar proteinosis, cryptococcal meningitis and severe nocardiosisRespiratory researchOctober 11, 2022Salvator H, Cheng A, Rosen LB, Williamson PR, Bennett JE, Kashyap A, Ding L, Kwon-Chung KJ, Namkoong H, Zerbe CS, et al.

(12) Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic TransformationCancer discoveryOctober 5, 2022Chen S, Vedula RS, Cuevas-Navarro A, Lu B, Hogg SJ, Wang E, Benbarche S, Knorr K, Kim WJ, Stanley RF, et al.

(13) Small-molecule screening identifies Syk kinase inhibition and rutaecarpine as modulators of macrophage training and SARS-CoV-2 infectionCell reportsOctober 4, 2022John SP, Singh A, Sun J, Pierre MJ, Alsalih L, Lipsey C, Traore Z, Balcom-Luker S, Bradfield CJ, Song J, et al.

(14) DLL4 and VCAM1 enhance the emergence of T cell-competent hematopoietic progenitors from human pluripotent stem cellsScience advancesAugust 26, 2022Michaels YS, Edgar JM, Major MC, Castle EL, Zimmerman C, Yin T, Hagner A, Lau C, Hsu HH, Ibañez-Rios MI, et al.

(15) Genetically Engineered Pigs as Efficient Salivary Gland Bioreactors for Production of Therapeutically Valuable Human Nerve Growth FactorCellsAugust 2, 2022Zeng F, Liao S, Kuang Z, Zhu Q, Wei H, Shi J, Zheng E, Xu Z, Huang S, Hong L, et al.

(16) CAF08 adjuvant enables single dose protection against respiratory syncytial virus infection in murine newbornsNature communicationsAugust 2, 2022van Haren SD, Pedersen GK, Kumar A, Ruckwardt TJ, Moin S, Moore IN, Minai M, Liu M, Pak J, Borriello F, et al.

(17) Synthetic amyloid beta does not induce a robust transcriptional response in innate immune cell culture systemsJournal of neuroinflammationApril 23, 2022Quiroga IY, Cruikshank AE, Bond ML, Reed KSM, Evangelista BA, Tseng JH, Ragusa JV, Meeker RB, Won H, Cohen S, et al.15 ng/ml recombinant human granulocyte–macrophage colony stimulating factor (rhGM-CSF; R&D Systems # 215-GM-010/CF). PBMC Mφ were allowed to differentiate for an additional 5 days and were returned to DMEM 10% FBS until

(18) The Thermal Dose of Photothermal Therapy Generates Differential Immunogenicity in Human Neuroblastoma CellsCancersMarch 11, 2022Sekhri P, Ledezma DK, Shukla A, Sweeney EE, Fernandes R.

(19) Synoviocytes from pigmented villonodular synovitis are less sensitive to cadmium-induced cell death than synoviocytes from rheumatoid arthritisScientific reportsMarch 9, 2022Farese H, Noack M, Miossec P.

(20) Macrophages activated by hepatitis B virus have distinct metabolic profiles and suppress the virus via IL-1β to downregulate PPARα and FOXO3Cell reportsJanuary 25, 2022Li Y, Zhu Y, Feng S, Ishida Y, Chiu TP, Saito T, Wang S, Ann DK, Ou JJ.